# MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

> **NCT02707107** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 20 (actual)

## Conditions studied

- Serious Gram-negative Infections

## Interventions

- **DRUG:** Intravenous infusions of WCK 5222
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02707107
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707107, "MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02707107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*